Informative audio tape summarizing new treatment advances including Telaprevir, R1626, Alinia and a new novel vaccine approach. Afdahl's take-away is that novel treatments (beyond SOC) are both exciting; are improving SVR rates over SOC with less treatment time: and that more exiting news is expected in the next 6-12 months.
For the full audio, free registration at Clinical Care Options is required (http://www.clinicaloptions.com/)
After registering, then go to the following link and scroll down to Nezam Afdhals' Audio File:
http://www.clinicaloptions.com/Hepatitis/Conference%20Coverage/Boston%202007.aspx